Shannon Fischer is a freelance science writer in Boston, Massachusetts. She once had ideas about becoming a scientist herself, but ultimately jumped ship for science writing and never looked back. She now writes about everything from debates over the true nature of human emotion, the life and times of rising mixed martial artists, 3D bioprinting, and the difficulties of putting squirrels on birth control. In addition to Pulse, her work has appeared in various places, including Pacific Standard online, the Smithsonian Zoogoer, and Boston magazine.
Femi Olugbile has had a close view of Nigeria’s health care progress over the years. Despite decades of economic booms and busts and sociopolitical turmoil
Every night, around the world, 7 billion people lie down to sleep. Their eyes close, their bodies relax, and their brain waves begin to smooth from the chaos of wakefulness into slower, synchronized waves
Three hundred eighty-two million people in the world have diabetes today. Of those, roughly 343.8 million have type 2 diabetes, 3.8 million have type 1, and 175 million don’t even know they have diabetes at all. On top of that, 316 million more people are at high risk for diabetes. Combined, that makes for just shy of 10% of the global population with or at risk for the disease right now
In 1979, a Hebrew University biochemist named Yechezkel Barenholz teamed with Alberto Gabizon, a newly minted Ph.D. from the Weizmann Institute of Science, to find a better way to give chemotherapeutic doxorubicin to patients with cancer…
Five years ago, Jeffrey Karp sat down to a dinner party with Massachusetts General Hospital dermatologist R. Rox Anderson..
When it comes to predicting the future, everyone has their own approach. Weather forecasters track changing pressure systems, economists study the markets, and doctors wrestle with patient risk factors. And here at Pulse? Over the last few months, we’ve talked to experts in the field, asked IEEE EMBS members for input, and scanned through the past year’s research breakthroughs to identify what we think might be the hottest biomedical engineering areas to watch in 2014.
When it comes to biomedical engineering (BME) today, innovation might just be the most important buzzword around. That’s not because it happens to be the trend of the day across industries already; it’s because in the face of skyrocketing healthcare costs, a rapidly aging global population, and multiplying cases of chronic diseases such as diabetes, cardiovascular disease, and cancer, we have no other choice. If our goal is ultimately to create a healthier, more vibrant global society, we must innovate—and radically.